Rifapentine Tablet, Film Coated
Product Images NDC 33342-599

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rifapentine (NDC 33342-599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

654 (Rifapentine Carton 24)

Rifapentine Tablets 150 mg film-coated oral tablets packaging label from Macleods Pharmaceuticals Limited. The carton contains 24 tablets in 3 blister strips of 8 unit-dose tablets each. Instructions for opening the blister pack are included. The label also provides storage instructions and highlights that the packaging is child-resistant.*

FDA Label Image

202 (Rifapentine Structure)

Chemical structure diagram of Rifapentine, showing the detailed molecular arrangement of atoms and bonds characteristic of this antibiotic agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.